GB2115811B - Ergot alkaloids - Google Patents
Ergot alkaloidsInfo
- Publication number
- GB2115811B GB2115811B GB08304011A GB8304011A GB2115811B GB 2115811 B GB2115811 B GB 2115811B GB 08304011 A GB08304011 A GB 08304011A GB 8304011 A GB8304011 A GB 8304011A GB 2115811 B GB2115811 B GB 2115811B
- Authority
- GB
- United Kingdom
- Prior art keywords
- ergot alkaloids
- ergot
- alkaloids
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
- C07D457/04—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 8
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
- C07D457/02—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with hydrocarbon or substituted hydrocarbon radicals, attached in position 8
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- General Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH98782 | 1982-02-17 |
Publications (3)
Publication Number | Publication Date |
---|---|
GB8304011D0 GB8304011D0 (en) | 1983-03-16 |
GB2115811A GB2115811A (en) | 1983-09-14 |
GB2115811B true GB2115811B (en) | 1985-08-14 |
Family
ID=4199836
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB08304011A Expired GB2115811B (en) | 1982-02-17 | 1983-02-14 | Ergot alkaloids |
Country Status (19)
Country | Link |
---|---|
JP (1) | JPS58152884A (en) |
AU (1) | AU1142083A (en) |
BE (1) | BE895898A (en) |
CS (1) | CS236786B2 (en) |
DD (1) | DD209458A5 (en) |
DE (1) | DE3304361A1 (en) |
DK (1) | DK66483A (en) |
ES (1) | ES8407060A1 (en) |
FI (1) | FI830462L (en) |
FR (1) | FR2521562B1 (en) |
GB (1) | GB2115811B (en) |
GR (1) | GR79562B (en) |
IT (1) | IT1197578B (en) |
NL (1) | NL8300558A (en) |
NO (1) | NO830482L (en) |
PL (1) | PL240608A1 (en) |
PT (1) | PT76242B (en) |
SE (1) | SE8300865L (en) |
ZA (1) | ZA831089B (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4734501A (en) * | 1985-10-01 | 1988-03-29 | Eli Lilly And Company | N-alkylation of dihydrolysergic acid |
GB0808326D0 (en) * | 2008-05-08 | 2008-06-18 | E Therapeutics Plc | Compositions and methods for the treatment of fybromyalgia |
-
1983
- 1983-02-09 DE DE19833304361 patent/DE3304361A1/en not_active Withdrawn
- 1983-02-10 FI FI830462A patent/FI830462L/en not_active Application Discontinuation
- 1983-02-14 BE BE1/10724A patent/BE895898A/en not_active IP Right Cessation
- 1983-02-14 FR FR8302463A patent/FR2521562B1/en not_active Expired
- 1983-02-14 GB GB08304011A patent/GB2115811B/en not_active Expired
- 1983-02-14 NO NO830482A patent/NO830482L/en unknown
- 1983-02-15 DK DK66483A patent/DK66483A/en not_active Application Discontinuation
- 1983-02-15 AU AU11420/83A patent/AU1142083A/en not_active Abandoned
- 1983-02-15 ES ES519811A patent/ES8407060A1/en not_active Expired
- 1983-02-15 NL NL8300558A patent/NL8300558A/en not_active Application Discontinuation
- 1983-02-16 PL PL24060883A patent/PL240608A1/en unknown
- 1983-02-16 JP JP58025455A patent/JPS58152884A/en active Pending
- 1983-02-16 SE SE8300865A patent/SE8300865L/en not_active Application Discontinuation
- 1983-02-16 PT PT76242A patent/PT76242B/en unknown
- 1983-02-16 GR GR70512A patent/GR79562B/el unknown
- 1983-02-17 DD DD83248035A patent/DD209458A5/en unknown
- 1983-02-17 CS CS831070A patent/CS236786B2/en unknown
- 1983-02-17 IT IT47734/83A patent/IT1197578B/en active
- 1983-02-17 ZA ZA831089A patent/ZA831089B/en unknown
Also Published As
Publication number | Publication date |
---|---|
IT1197578B (en) | 1988-12-06 |
GR79562B (en) | 1984-10-30 |
FR2521562B1 (en) | 1985-10-25 |
PL240608A1 (en) | 1984-10-08 |
ZA831089B (en) | 1984-09-26 |
BE895898A (en) | 1983-08-16 |
JPS58152884A (en) | 1983-09-10 |
NL8300558A (en) | 1983-09-16 |
FI830462A0 (en) | 1983-02-10 |
DE3304361A1 (en) | 1983-08-25 |
SE8300865D0 (en) | 1983-02-16 |
DK66483A (en) | 1983-08-18 |
DK66483D0 (en) | 1983-02-15 |
ES519811A0 (en) | 1984-08-16 |
PT76242A (en) | 1983-03-01 |
AU1142083A (en) | 1983-08-25 |
GB2115811A (en) | 1983-09-14 |
ES8407060A1 (en) | 1984-08-16 |
GB8304011D0 (en) | 1983-03-16 |
PT76242B (en) | 1986-01-10 |
IT8347734A0 (en) | 1983-02-17 |
FR2521562A1 (en) | 1983-08-19 |
SE8300865L (en) | 1983-08-18 |
CS236786B2 (en) | 1985-05-15 |
DD209458A5 (en) | 1984-05-09 |
NO830482L (en) | 1983-08-18 |
FI830462L (en) | 1983-08-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB8311973D0 (en) | Quinoline derivatives | |
DE3377796D1 (en) | Quinoline derivatives | |
ZA833008B (en) | Ergoline derivatives | |
GB2125041B (en) | Ergot alkaloids | |
AU553514B2 (en) | Vinca alkaloids | |
GB8303475D0 (en) | Ergot alkaloids | |
PT72785A (en) | Ergoline derivatives | |
GB2115811B (en) | Ergot alkaloids | |
GB2074566B (en) | Ergoline derivatives | |
GB2092570B (en) | Ergot alkaloids | |
ZA812103B (en) | Ergoline derivatives | |
NZ189422A (en) | Ergot peptide alkaloids | |
ZA83955B (en) | Ergot alkaloids | |
GB2094798B (en) | Ergot alkaloids | |
PH20160A (en) | Ergoline derivatives | |
JPS57159783A (en) | Manufacture of ergot alkaloids | |
GB2131674B (en) | Ashtray | |
IE802091L (en) | Ergot peptide alkaloids | |
GB2135307B (en) | Ergot derivatives | |
KR840000329Y1 (en) | Ashtray | |
KR860000957Y1 (en) | Ashtray | |
GB8312447D0 (en) | Ergot derivatives | |
ZA841150B (en) | Ergot derivatives | |
IE822659L (en) | Morphinane derivatives | |
IE820346L (en) | Quinoline derivatives |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PCNP | Patent ceased through non-payment of renewal fee |